You Can Be A Reason for Hope

Cancer research and drug development is time-consuming and expensive, and the CHRISTUS Stehlin Foundation for Cancer Research is thankful for the dedication and generosity of its many supporters.

The Foundation currently receives 100 percent of its funding from donations by individuals, private foundations, and corporate partners. Neither Stehlin’s research programs nor its clinical trials of anticancer drugs receive support from state or federal agencies.

What Can You Do?

There are so many ways to show your support for the life-changing work of Stehlin scientists:

Choose a project of interest and make a donation – large or small, one time or recurring.
Volunteer your valuable time in support of a fundraising event.
Include the Foundation in your estate plan.

Join the fight to bring help and hope to cancer patients and families from now into the future.

Click to View Other Ways to Give

Join the Fight

Click for this page's content [s] — or continue for possible special messages and page’s footer.

We Depend on You

Stehlin’s entire annual operating budget currently is funded by private donations.

The Foundation’s audited financial statements and federal tax Forms 990 are available here. For more information, contact our Development office by email or phone 713-659-1336.

News

In Mice, Cancer Drug Shows Effect on Alzheimer's Symptoms

The cancer drug bexarotene quickly eliminates Alzheimer's disease-associated amyloid beta from the brain and reverses memory problems in mice, a new study finds. The results suggest that bexarotene could help the 5.4 million Americans with Alzheimer's disease.

Genetic Breakthrough for Brain Cancer in Children

An international research team has made a breakthrough that could change the way pediatric cancers are treated in the future. The researchers identified two genetic mutations responsible for up to 40 per cent of glioblastomas in children.

All News